“…During the use of heparin in the complete ECLS, activated clotting time (ACT) targets were reported in 35 patients, 13,17,27,31,37,42,45,47,54,55,58,59,61,62,66,73,79,82,89,90,92,93 and activated partial thromboplastin time (aPTT) targets were reported in 10 patients. 20,21,26,40,73,95 In the subgroup with different anticoagulation other than heparin, ACT targets were defined in four patients, 36,38,48,52 whereas no specific mention of anticoagulation assessment was available in the other studies.…”